Figure 4From: Evaluation of blood-brain barrier transport and CNS drug metabolism in diseased and control brain after intravenous L-DOPA in a unilateral rat model of Parkinson's diseasePopulation predicted concentrations of DOPAC (panel A) and HVA (panel B) in the control cerebral hemisphere (-) and rotenone-treated responder cerebral hemisphere in responders (---) according to the model as described in Figure 1, at three doses of L-DOPA.Back to article page